首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   126篇
  免费   5篇
儿科学   1篇
基础医学   25篇
口腔科学   1篇
临床医学   29篇
内科学   22篇
皮肤病学   1篇
神经病学   8篇
特种医学   5篇
外科学   19篇
综合类   1篇
预防医学   8篇
眼科学   5篇
药学   3篇
肿瘤学   3篇
  2023年   7篇
  2022年   12篇
  2021年   8篇
  2020年   1篇
  2019年   3篇
  2018年   4篇
  2017年   2篇
  2015年   1篇
  2014年   6篇
  2013年   4篇
  2012年   9篇
  2011年   7篇
  2010年   6篇
  2009年   7篇
  2008年   6篇
  2007年   9篇
  2006年   8篇
  2005年   7篇
  2004年   2篇
  2003年   2篇
  2002年   7篇
  2001年   1篇
  1999年   2篇
  1990年   1篇
  1989年   3篇
  1988年   1篇
  1986年   2篇
  1985年   1篇
  1981年   1篇
  1978年   1篇
排序方式: 共有131条查询结果,搜索用时 343 毫秒
11.
12.
The effects of 3 stretching methods on the motor pool excitability of the soleus muscle as measured by the Hoffmann reflex have been compared with the objective of revealing central nervous system influences promoting muscle compliance to lengthening. The H-wave was reduced slightly throughout the static stretch method. The contract-relax (CR) method produced profound inhibition during the first several hundred milliseconds following contraction, but gradually increased to values similar to static stretch (SS) values 2 sec following contraction. Hoffmann reflex values for the contract-relax-antagonist-contract (CRAC) method were greatly depressed throughout the stretching phase with a slight increase after 2 sec. It was concluded that several inhibitory neural influences can have an additive effect in profoundly reducing motor pool excitability. Under the assumption that greater motor pool inhibition reduces muscle contractibility and therefore allows more muscle compliance, it is suggested that the proprioceptive neuromuscular facilitation (PNF) methods, particularly those involving reciprocal activation, provide the greatest potential for muscle lengthening. This is supported by previous studies which compared gains in range of motion using these 3 stretching methods (Holt et al. 1970; Moore and Hutton 1980; Etnyre and Abraham 1985).  相似文献   
13.
14.
OBJECTIVES: A recent study showed that estimates of cost-effectiveness submitted to National Institute for Health and Clinical Excellence (NICE) by manufacturers had significantly lower incremental cost-effectiveness ratios (ICERs) than those submitted by university-based Assessment Groups. This study extends that analysis. METHODS: Data were abstracted from relevant NICE documentation for thirty-two of eighty-two possible appraisals. RESULTS: The results from the analysis showed that sources of the difference in ICERs appear to be the effectiveness estimates relating to the comparator technology and the cost estimates relating to the technology under evaluation. That is, manufacturers estimated lower average benefits for the comparator technology and lower costs relating to the technology under evaluation compared with estimates submitted by the Assessment Groups. CONCLUSIONS: These findings may be particularly important, given the introduction of the "Single Technology Appraisal." Considerable difficulties were encountered when undertaking this study, highlighting, above all else, the complexity of explaining why results from economic evaluations purporting to answer the same question diverge.  相似文献   
15.
Differentiating the early stages of Parkinson's disease from the normal consequences of aging or from other common neurologic conditions can be diagnostically problematic. The purpose of this study was to compare methodologies for measuring motor neuron excitability of Parkinson's disease patients with a control group. H-reflexes were monitored in 16 patients diagnosed in the early stages of Parkinson's disease (Hoehn & Yahr stages I and II) compared with 30 subjects who were disease free. Methods of measurement included H-reflex latencies, the relative values of maximum H-reflexes to maximum direct motor responses (H-to-M ratio), the relative values of H-reflex amplitudes during vibration compared with control H-reflex amplitudes (Hv-to-Hc ratio), and double-stimulation H-reflex recovery curves using different interstimulus interval parameters. No significant differences were observed for the H-to-M or Hv-to-Hc ratios, or for the H-reflex latencies. The H-reflex recovery curves for the patients with Parkinson's disease demonstrated significantly greater ratio amplitudes than the control group during the double-stimulus responses between the 150-msec and 700-msec interstimulus intervals. Although comparisons of simple H-reflexes and H-reflexes during vibration did not differentiate the patients in the early stages of Parkinson's disease from the control group, the double-stimulation paradigm was a sensitive method for detecting early diagnoses of this disease.  相似文献   
16.
17.
18.

Objectives

The aim of this paper is to summarize concerns with the de-identification standard and methodologies established under the Health Insurance Portability and Accountability Act (HIPAA) regulations, and report some potential policies to address those concerns that were discussed at a recent workshop attended by industry, consumer, academic and research stakeholders.

Target audience

The target audience includes researchers, industry stakeholders, policy makers and consumer advocates concerned about preserving the ability to use HIPAA de-identified data for a range of important secondary uses.

Scope

HIPAA sets forth methodologies for de-identifying health data; once such data are de-identified, they are no longer subject to HIPAA regulations and can be used for any purpose. Concerns have been raised about the sufficiency of HIPAA de-identification methodologies, the lack of legal accountability for unauthorized re-identification of de-identified data, and insufficient public transparency about de-identified data uses. Although there is little published evidence of the re-identification of properly de-identified datasets, such concerns appear to be increasing. This article discusses policy proposals intended to address de-identification concerns while maintaining de-identification as an effective tool for protecting privacy and preserving the ability to leverage health data for secondary purposes.  相似文献   
19.
20.
Capillary leak syndrome (CLS) is a rare clinical syndrome associated with significant morbidity and mortality. Intensive care and supportive therapy constitute the mainstay of the treatment, along with judicious use of crystalloids and colloids such as dextran and starch during the leak phase. The advantages of proning, steroids, and intravenous immunoglobins are worth contemplating in patients with such a presentation. Extracorporeal membrane oxygenation appears to be an excellent strategy to surmount the impediments of the leak and post leak phase of CLS, especially in patients with severe or refractory hypoxemia.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号